• Corpus ID: 440540

[Chemical studies of Salvia miltiorrhiza f. alba].

@article{Li1991ChemicalSO,
  title={[Chemical studies of Salvia miltiorrhiza f. alba].},
  author={Z T Li and B. J. Yang and Guoyi Ma},
  journal={Yao xue xue bao = Acta pharmaceutica Sinica},
  year={1991},
  volume={26 3},
  pages={
          209-13
        }
}
Fourteen constituents were isolated from the roots of Salvia miltiorrhiza f. alba. Two of them were new compounds and were named 1,2,15,16-tetrahydrotanshiquinone (I) and tanshinaldehyde (II). The others were identified as Ro-090680 (III), dihydroisotanshone I (IV), danshexinkun B (V), miltirone (VI), nortanshinone (VII), hydroxytanshinone II-A (VIII), tanshinone I (IX), dihydrotanshinone I (X), tanshinone II-A (XI), cryptotanshinone (XII), methylenetanshiquinone (XIII), methyltanshinonate (XIV… 

Pharmacophylogenetic Study on Plants of Genus Salvia L. from China

Abstract In China, many species of genus Salvia L. (Lamiaceae) are important medicinal plants with a long history. Due to their marked ethnopharmacological uses in folk medicine and a large number of

Phytochemistry and pharmacogenomics of natural products derived from traditional chinese medicine and chinese materia medica with activity against tumor cells

This work has done a systematic bioactivity-based screening of natural products derived from medicinal plants used in traditional Chinese medicine, and identified 25-O-acetyl-23,24-dihydro-cucurbitacin F as a cytotoxic constituent of Quisqualis indica.

Genetic diversity and phylogeny analysis of 3-hydroxy 3-methylglutaryl-CoA reductase gene (SmHMGR) in Danshen (Salvia miltiorrhiza Bunge)

The genomic SmHMGR genes of 38 cultivated populations of S. miltiorrhiza collected in China were for the first time sequenced to reveal the genetic diversity and phylogeny and showed a very similar two-clade topological structure.

Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction

It was found that the active components in SMB mainly treated CI by regulating key proteins such as AKT1, IL-6, and EGFR, indicating that SMB has some scientificity in the treatment of CI.